Overview

Safety and Tolerability of AZD5148 in Japanese Participants

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-01-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure safety, tolerability and PK of a single dose of AZD5148 administered via IV bolus or IM injection in healthy Japanese participants.
Phase:
PHASE1
Details
Lead Sponsor:
AstraZeneca